Advertisement

Incidence of Creutzfeldt-Jakob Disease in the European Community

  • R. G. Will
Part of the Serono Symposia USA Norwell, Massachusetts book series (SERONOSYMP)

Abstract

Epidemiologic surveillance of Creutzfeldt-Jakob disease (CJD) was reinstituted in the United Kingdom in 1990 following a recommendation by the Southwood Committee (1). The aim of the surveillance program is to determine whether there is a change in the epidemiologic or clinicopathologic features of CJD as a result of transmission of bovine spongiform encephalopathy (BSE) to the human population, should this indeed occur. National surveillance programs for CJD have been established in France, Germany, Italy, and the Netherlands, and all these European projects now share common methodologies, assisted by a grant awarded through the BIOMED1 program. The importance of conducting epidemiologic research in CJD has been heightened by the occurrence of BSE in several member states of the European Community (EC) and an increased level of controversy about the perceived risk posed by BSE. The risk to the human population has been judged to be remote by a range of official bodies including the Southwood Committee, the United Kingdom Agricultural Select Committee, EC committees, and the World Health Organization (2). This consensus has been challenged, often on the basis of assertion rather than scientific evidence. An assessment of the risk posed by BSE must inevitably be based on an assessment of a body of scientific information including evidence from transmission studies, molecular biology, and protein chemistry. However, currently the only direct evidence on whether or not BSE has caused disease in the human population is from epidemiologic surveillance.

Keywords

Dura Mater Prion Disease Bovine Spongiform Encephalopathy Human Growth Hormone Neurol Neurosurg Psychiatry 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Southwood Committee. Report of the Working Party on Bovine Spongiform Encephalopathy. Department of Health and Ministry of Agriculture, Fisheries and Food. ISBN 1989;185197 405 9.Google Scholar
  2. 2.
    World Health Organization. Report of a WHO consultation on public health issues related to animal and human spongiform encephalopathies. Geneva, 12–14 November, 1991.Google Scholar
  3. 3.
    Creutzfeldt-Jakob Disease Surveillance in the United Kingdom—Third Annual Report. Edinburgh: CJD Surveillance Unit, 1994.Google Scholar
  4. 4.
    Powell-Jackson J, Weiler RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J. Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 1985;2:244–246.PubMedCrossRefGoogle Scholar
  5. 5.
    Esmonde TFG, Lueck CJ, Symon L, Duchen LW, Will RG. Creutzfeldt-Jakob disease and Iyophilised dura mater grafts: report of two cases. J Neurol Neurosurg Psychiatry 1993;56:999–1000.PubMedCrossRefGoogle Scholar
  6. 6.
    Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB. Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113–1119.PubMedCrossRefGoogle Scholar
  7. 7.
    Will RG, Matthews WB, Smith PG, Hudson C. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–1979. II: Epidemiology. J Neurol Neurosurg Psychiatry 1986;49:749–755.PubMedCrossRefGoogle Scholar
  8. 8.
    Alperovitch A, Brown P, Weber T, Pocchiari M, Hofman A, Will RG. Incidence of Creutzfeldt-Jakob disease in Europe 1993. Lancet 1994;343:918.PubMedCrossRefGoogle Scholar
  9. 9.
    Satishchandra P, Shankar SK. Creutzfeldt-Jakob disease in India (1971–1990). Neuroepidemiology 1991;10:27–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Will RG. Is there a potential risk of transmission of BSE to the human population and how may this be assessed? In: Bradley R, Savey M, Marchant B, eds. Sub-acute spongiform encephalopathies. Dordrecht: Kluwer Academic Publishers for the EEC, 1991:179–186.Google Scholar
  11. 11.
    Marsh RF. Transmissible mink encephalopathy. In: Prusiner SB, Collinge J, Powell J, Anderton B, eds. Prion diseases of humans and animals. Proceedings of Prion Diseases of Humans and Animals, London 2–4 September, 1992. Chichester: Ellis Horwood, 1992:300–307.Google Scholar
  12. 12.
    Robinson MM. Transmissible encephalopathy research in the United States. Transmissible spongiform encephalopathies. Proceedings of a consultation on BSE with the Scientific Veterinary Committee of the European Communities held in Brussels, 14–15 September 1993, Brussels: European Commission, 1993:261–269.Google Scholar
  13. 13.
    Cousens SN, Harries-Jones R, Knight R, Will RG, Smith PG, Matthews WB. Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970–84. J Neurol Neurosurg Psychiatry 1990;53:459–465.PubMedCrossRefGoogle Scholar
  14. 14.
    Brown P, Cathala F, Sadowsky D. Correlation between population density and the frequency of Creutzfeldt-Jakob disease in France. J Neurol Sci 1983;60: 169–176.PubMedCrossRefGoogle Scholar
  15. 15.
    Galvez S, Masters C, Gajdusek DC. Descriptive epidemiology of Creutzfeldt-Jakob disease in Chile. Arch Neurol 1980;37:11–14.PubMedGoogle Scholar
  16. 16.
    Sawcer SJ, Yuill GM, Esmonde TFG, et al. Creutzfeldt-Jakob disease in an individual occupationally exposed to BSE. Lancet 1993;341:642.PubMedCrossRefGoogle Scholar
  17. 17.
    Davies PTG, Jahfar S, Ferguson IT. Creutzfeldt-Jakob disease in individual occupationally exposed to BSE. Lancet 1993;342:680.PubMedCrossRefGoogle Scholar
  18. 18.
    Schoene WC, Masters CL, Gibbs CJ Jr, et al. Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease). Atypical clinical and pathological findings. Arch Neurol 1981;38(8):473–477.PubMedGoogle Scholar
  19. 19.
    Gorman DG, Benson F, Vogel DG, Vinters HV. Creutzfeldt-Jakob disease in a pathologist. Neurology 1992;42:463.PubMedGoogle Scholar
  20. 20.
    Miller DC. Creutzfeldt-Jakob disease in histopathology technicians. N Engl J Med 1988;318:853–854.CrossRefGoogle Scholar
  21. 21.
    Sitwell L, Lach B, Atack E, Atack D. Creutzfeldt-Jakob disease in histopathology technicians. N Engl J Med 1988;318:854.Google Scholar
  22. 22.
    Weber T, Tumani H, Holdorff B, Collinge J, Palmer M, Kretzschmar HA, Felgenhauer K. Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet 1993;341:123–124.PubMedCrossRefGoogle Scholar
  23. 23.
    Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987;37:895–904.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • R. G. Will

There are no affiliations available

Personalised recommendations